Clariant Past Earnings Performance
Past criteria checks 2/6
Clariant has been growing earnings at an average annual rate of 6.9%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 2.4% per year. Clariant's return on equity is 6.8%, and it has net margins of 2.8%.
Key information
6.9%
Earnings growth rate
6.9%
EPS growth rate
| Chemicals Industry Growth | 12.9% |
| Revenue growth rate | 2.4% |
| Return on equity | 6.8% |
| Net Margin | 2.8% |
| Next Earnings Update | 29 Oct 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Clariant makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Jun 24 | 4,163 | 118 | 697 | 133 |
| 31 Mar 24 | 4,270 | 143 | 668 | 136 |
| 31 Dec 23 | 4,377 | 168 | 639 | 138 |
| 30 Jun 23 | 4,919 | -98 | 677 | 142 |
| 31 Mar 23 | 5,059 | -115 | 711 | 146 |
| 31 Dec 22 | 5,198 | -133 | 745 | 150 |
| 30 Sep 22 | 5,050 | 107 | 725 | 154 |
| 30 Jun 22 | 4,901 | 346 | 705 | 157 |
| 31 Mar 22 | 4,637 | 305 | 700 | 157 |
| 31 Dec 21 | 4,372 | 263 | 694 | 156 |
| 30 Sep 21 | 4,161 | 199 | 672 | 158 |
| 30 Jun 21 | 3,949 | 135 | 649 | 159 |
| 31 Mar 21 | 3,905 | 121 | 665 | 159 |
| 31 Dec 20 | 3,860 | 106 | 681 | 159 |
| 30 Jun 20 | 4,115 | 141 | 1,010 | 166 |
| 31 Mar 20 | 4,257 | 40 | 1,019 | 171 |
| 31 Dec 19 | 4,399 | -62 | 1,027 | 175 |
| 30 Jun 19 | 4,409 | -67 | 865 | 176 |
| 31 Mar 19 | 4,407 | 64 | 861 | 175 |
| 31 Dec 18 | 4,404 | 194 | 856 | 174 |
| 30 Sep 18 | 4,937 | 223 | 922 | 182 |
| 30 Jun 18 | 5,469 | 251 | 987 | 190 |
| 31 Mar 18 | 5,923 | 264 | 1,072 | 197 |
| 31 Dec 17 | 6,377 | 277 | 1,157 | 203 |
| 30 Sep 17 | 6,229 | 276 | 1,130 | 201 |
| 30 Jun 17 | 6,080 | 274 | 1,102 | 199 |
| 31 Mar 17 | 5,964 | 264 | 1,093 | 199 |
| 31 Dec 16 | 5,847 | 253 | 1,084 | 199 |
| 30 Sep 16 | 5,899 | 211 | 1,083 | 208 |
| 30 Jun 16 | 5,835 | 203 | 1,092 | 208 |
| 31 Mar 16 | 5,792 | 195 | 1,063 | 207 |
| 31 Dec 15 | 5,807 | 217 | 1,067 | 204 |
| 30 Sep 15 | 5,867 | 275 | 1,064 | 199 |
| 30 Jun 15 | 5,964 | 272 | 1,061 | 203 |
| 31 Mar 15 | 6,089 | 299 | 1,076 | 208 |
| 31 Dec 14 | 6,116 | 175 | 1,049 | 213 |
| 30 Sep 14 | 6,093 | 177 | 1,058 | 212 |
| 30 Jun 14 | 6,029 | 245 | 1,024 | 208 |
| 31 Mar 14 | 6,042 | 231 | 1,039 | 203 |
| 31 Dec 13 | 6,076 | 306 | 1,049 | 199 |
Quality Earnings: CLZN.F has a large one-off loss of CHF145.0M impacting its last 12 months of financial results to 30th June, 2024.
Growing Profit Margin: CLZN.F became profitable in the past.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLZN.F has become profitable over the past 5 years, growing earnings by 6.9% per year.
Accelerating Growth: CLZN.F has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: CLZN.F has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (-7.7%).
Return on Equity
High ROE: CLZN.F's Return on Equity (6.8%) is considered low.